semaglutide canada patent expiry Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent As the patent for semaglutide,

Food and Drug Administration News Reports (NY Post / Verywell Health) contextualizes Retatrutide as the next-generation triple G therapy capable of greater weight loss, and notes timeline expectations for approval (~late 20252026) Wikipedia+15verywellhealth.com+15New York Post+15

Lipo B12+MIC FAQ What is Lipotropic (Lipo) B12+MIC

Benefit: Reduces melanin production, removes tan, and brightens complexion

Flippase is an enzyme active under basal conditions that shifts PS from the outer to the inner membrane leaflet, thereby preventing PS exposure

Prescribing unapproved drugs is not routine medical practice Without FDA approval or an authorized investigational pathway, licensed providers do not have authority to prescribe experimental compounds as treatment